This report contains market size and forecasts of Biosimilars/follow-on-biologics in China, including the following market information:
China Biosimilars/follow-on-biologics Market Revenue, 2016-2021, 2022-2027, ($ millions)
China top five Biosimilars/follow-on-biologics companies in 2020 (%)
The global Biosimilars/follow-on-biologics market size is expected to growth from US$ 9291.3 million in 2020 to US$ 11500 million by 2027; it is expected to grow at a CAGR of 3.1% during 2021-2027.
The China Biosimilars/follow-on-biologics market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Biosimilars/follow-on-biologics Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Biosimilars/follow-on-biologics Market,
China Biosimilars/follow-on-biologics Market Segment Percentages,
Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
China Biosimilars/follow-on-biologics Market,
China Biosimilars/follow-on-biologics Market Segment Percentages,
Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilars/follow-on-biologics revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Biosimilars/follow-on-biologics revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
China Biosimilars/follow-on-biologics Market Revenue, 2016-2021, 2022-2027, ($ millions)
China top five Biosimilars/follow-on-biologics companies in 2020 (%)
The global Biosimilars/follow-on-biologics market size is expected to growth from US$ 9291.3 million in 2020 to US$ 11500 million by 2027; it is expected to grow at a CAGR of 3.1% during 2021-2027.
The China Biosimilars/follow-on-biologics market was valued at US$ XX million in 2020 and is projected to reach US$ XX million by 2027, at a CAGR of XX% during the forecast period.
QYResearch has surveyed the Biosimilars/follow-on-biologics Companies and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
China Biosimilars/follow-on-biologics Market,
By Type
, 2016-2021, 2022-2027 ($ Millions)China Biosimilars/follow-on-biologics Market Segment Percentages,
By Type
, 2020 (%)Human growth hormone
Erythropoietin
Monoclonal antibodies
Insulin
Interferon
Granulocyte-Colony Stimulating Factor
Others
China Biosimilars/follow-on-biologics Market,
By Application
, 2016-2021, 2022-2027 ($ Millions)China Biosimilars/follow-on-biologics Market Segment Percentages,
By Application
, 2020 (%)Blood Disorders
Oncology Diseases
Chronic and Autoimmune Diseases
Growth Hormone Deficiencies
Others
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Biosimilars/follow-on-biologics revenues in China market, 2016-2021 (Estimated), ($ millions)
Key companies Biosimilars/follow-on-biologics revenues share in China market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novartis (Sandoz)
Synthon Pharmaceuticals
Teva Pharmaceutical Industries
LG Life Sciences
Celltrion Biocon
Hospira
Merck Serono (Merck)
Biogen idec
Genentech (Roche)
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.